Henry Schein, US42548G1040

Henry Schein stock heads into the open after a 1.99% drop

Published on 09/18/2026 at 05:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 17, 2026, Henry Schein stock finished at USD 85.04 on Nasdaq, down 1.99%. The shares traded between USD 84.60 and USD 86.32 on the day and moved broadly in line with major US indexes.

Isometrische 3D-Illustration der Lieferkette von Medizinprodukten von Produktion zu Klinik
Henry Schein US42548G1040 Wertschöpfungskette vom Hersteller über Lager bis zur Zahnarztpraxis isometrisch dargestellt, Illustration mit AI erstellt.

Henry Schein stock closed at USD 85.04 on Nasdaq on September 17, 2026, down 1.99% from the prior session. The shares traded between roughly USD 84.60 and USD 86.32 during the day, with turnover near their recent average, while major US indexes also saw modest moves.

September 17, 2026 in numbers

Henry Schein Inc. (ISIN US42548G1040, Nasdaq: HSIC) ended the September 17, 2026 session at USD 85.04 on Nasdaq after slipping 1.99%. Data from Nasdaq via Yahoo Finance show that the stock’s intraday range on that day stayed between about USD 84.60 at the low and roughly USD 86.32 at the high, with trading volume close to its typical daily level. Per the same quote overview, the move left the shares a few percent below their recent highs but still within the established 52-week trading band.

In a recent wrap highlighting the week’s trading, Ad-hoc-news noted that Henry Schein shares had previously reacted to an earnings outlook discussion, with expectations for fiscal year 2026 earnings per share around USD 5.36 and a recent close at USD 86.77 on September 16, 2026. Against that backdrop, the closing level of USD 85.04 on September 17, 2026 represented a modest pullback of about 2% from the prior day’s Nasdaq close.

Today’s focus for Henry Schein

For today, September 18, 2026, investors face the US open without a newly scheduled company-specific event such as an earnings release or annual meeting that would directly anchor Henry Schein’s trading. Recent commentary on earnings expectations, as cited by Ad-hoc-news, keeps attention on how the company’s guidance and demand trends may evolve into the next reporting cycle. Broader moves in US equity benchmarks and sector peers in the health-care and medical distribution space are likely to shape the backdrop for Henry Schein stock as the new session begins.

Disclaimer...

en | US42548G1040 | HENRY SCHEIN | boerse | 70121698 | bgmi